Quris AI

We’re happy to take part in the Longevity Investors Conference in Gstaad, Switzerland, where our Founder & CEO, Isaac Bentwich, will be speaking.

During these challenging days, we remain committed to continuing our work with purpose and resilience. With profound gratitude, speaking at the Tel Aviv Family Office & High Net Worth Annual Conference was a pleasure, sharing insights on a topic vital to our mission at Quris AI. We are proud to be at the forefront of an industry that convenes voices shaping the future—from health and climate innovation to next-gen family business leadership. In my talk, "How AI is Transforming Longevity," I explored how combining AI with miniature versions of human organs—grown on a chip—is changing the future of medicine. This breakthrough enables faster, safer, and more personalized drug development, opening the door to longer, healthier lives. Many thanks to Orit Rabin and DC Finance's Global Family Office & High Net Worth Community for hosting an incredibly thoughtful day at the Tel Aviv Stock Exchange. Looking forward to continued collaboration, deeper conversations, and the exciting future that lies ahead. #Longevity #AI #HealthTech #FutureOfInvesting #QurisAI #TelAviv #FamilyOffice #Innovation

Quris is proud to join Tmura as Donor Company! 🎉 We've donated company options, directly supporting their mission to "Share a Little Upside with Society." This initiative channels tech success back into the Israeli community, empowering vital public service programs that help maximize future social good. We hope that many more companies will join this meaningful initiative as well!

We're thrilled to announce that Quris AI has been featured in the latest CB Insights "AI in drug R&D market map" as one of the top 3 leading companies in the critical category of Toxicology & In Vivo Study Platforms within Pre-clinical Development! This recognition is a powerful testament to our unique approach to accelerating drug discovery by de-risking candidates early, reducing reliance on animal testing, and ultimately bringing safer, more effective medicines to patients faster. We're incredibly proud of our team and our mission to set new standards in drug development. Explore the full market map and discover the future of AI in pharma: https://lnkd.in/dZa-Gw-X #QurisAI #AIDrugDiscovery #PreclinicalDevelopment #Toxicology #InVivoStudies #Biotech #AIinPharma #DrugSafety #Innovation #CBInsights

As proud Bronze Sponsors, we invite you to join us at AI Week TLV 2025, Israel's most prestigious AI event! AI Week TLV provides a comprehensive showcase of the latest and most impactful advancements propelling the fields of artificial intelligence, bringing together leading researchers, innovators, and industry professionals to explore cutting-edge research, practical applications, and future trends. Join us from June 25–26, 2025, at Tel Aviv University to connect with global thought leaders, pioneering startups, and key players shaping the future of cybersecurity and AI. To register for AI Week: https://ai-week.com/ #AIWeekTLV #Innovation #TechLeadership #TelAvivUniversity

We were proud to see our Founder & CEO, Dr. Isaac Bentwich, speak at Biomed Israel 2025 on the panel “Aging Redefined: Breakthroughs in Science and Technology in Longevity,” moderated by Dr. Varda Shalev. A distinguished group of panelists explored diverse perspectives on longevity—from decoding the genetic blueprint of aging to transforming the field through BioAI, signaling a new era in science. Among the impressive speakers were Prof. Uri Alon, Prof. Leon Grunhaus, Mor Laila Pecht, Yuval Naveh, Dr. Galit Kaufman (RN, PhD), Itai Galili, Michael Latar, and Dr. Kevin Slawin MD. Many thanks for the engaging dialogue and to all the visionary panel participants. With such leadership and collaboration, the future of aging looks brighter than ever. #Biomed2025 #QurisAI #Longevity #BioAI #ClinicalTrials #HealthEquity #DigitalHealth #AgingInnovation #FutureOfMedicine

We were pleased to host the AstraZeneca Israel team at Quris-AI for an engaging and insightful session focused on our Bio-AI platform and our shared vision of transforming drug safety testing. Thank you for the meaningful discussions and for recognizing the power of integrating AI with organoid technology to drive a truly human-relevant approach to drug development. We look forward to continuing our collaboration and exploring how we can jointly push the boundaries of bioconvergence and predictive safety science. This dialogue is especially timely in light of the FDA’s recent announcement, which underscores the global shift toward next-generation, animal-free testing models. #QurisAI #AstraZeneca #BioAI #DrugSafety #Organoids #Bioconvergence #FutureOfMedicine #HumanRelevantScience #Collaboration

What if we could predict how a patient will respond to a drug before the first human trial begins? This isn't a hypothetical – the capability driving the critical transformation in drug development is here. Quris-AI is at the forefront of this shift, and our pivotal role in accelerating this movement is proudly featured in Drug Discovery World! Our AI-powered Patient-on-a-Chip platform is pioneering a human-centric approach, moving beyond the limitations of traditional animal testing. By leveraging human-derived cells and advanced machine learning, we create sophisticated simulations that provide predictive insights into drug response with unprecedented accuracy and ethical integrity. Dive into the full article to explore how we're pioneering this essential shift: https://lnkd.in/eFys3Xsw #QurisAI #PatientOnAChip #DrugDevelopment #AIinMedicine #AnimalFreeTesting #Biotech #ClinicalPrediction #FutureOfHealth #Pharma #Innovation #LifeSciences

The future of drug development is human-centric — and the shift is already underway. In a new PharmaCircle feature, our CEO, Dr. Isaac Bentwich, outlines how Quris-AI’s Patient-on-a-Chip platform is helping pharma companies move beyond traditional animal models. By combining human-derived cells with advanced machine learning, our platform delivers predictive, human-relevant insights into drug safety and efficacy — sidestepping the translational limitations of animal testing and accelerating smarter clinical development. Read the full article to understand how this shift is reshaping preclinical strategy: https://lnkd.in/dnshFY_X Stay updated on innovation in pharma: https://lnkd.in/epMmA8wk #QurisAI #DrugDevelopment #PatientOnAChip #PharmaCircle #AnimalFreeTesting #AIinMedicine #ClinicalPrediction #FutureOfPharma #Biotech #Innovation #RegulatoryScience

This week, our CEO, Dr. Isaac Bentwich, joined senior leaders from Microsoft, Google, KPMG — and longevity AI pioneer Prof. Alex Zhavoronkov (Founder & CEO, Insilico Medicine) — at the 2nd Sheba Longevity Conference for a powerful discussion on AI and Innovation in Longevity. The panel, held at Sheba Medical Center, Tel Hashomer, and organized by the ARC Innovation Center, explored how AI can revolutionize aging-related care and accelerate drug development. Dr. Bentwich shared how Quris-AI’s patient-on-a-chip platform is pioneering a safer, faster, and more personalized approach to longevity-focused treatments — helping reduce clinical trial failures while scaling precision medicine. We're proud to stand alongside global tech and biotech leaders in shaping the future of health and contributing to science that makes longer, healthier lives more attainable. Thank you to Welltech Ventures, Amir Alroy, Abigail Goshen, Evelyn Bishop, and Tzipi Strauss for your leadership and support in making this exceptional event possible. #QurisAI #Longevity #AIinMedicine #PatientOnAChip #PrecisionMedicine #HealthTech #ShebaConference #ARCInnovation #FutureOfHealth #WelltechVentures #DrugDiscovery #InsilicoMedicine